A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 136, Issue 12, Pages 2940-2948
Publisher
Wiley
Online
2014-11-18
DOI
10.1002/ijc.29344
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins
- (2013) Stephen B. Keysar et al. Molecular Oncology
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Expression of PIK3CA mutant E545K in the mammary gland induces heterogeneous tumors but is less potent than mutant H1047R
- (2013) D S Meyer et al. Oncogenesis
- Exploring biomarkers in head and neck cancer
- (2012) Corey J. Langer CANCER
- PIK3CA Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials
- (2012) F. Janku et al. CANCER RESEARCH
- Current advances in humanized mouse models
- (2012) Ryoji Ito et al. Cellular & Molecular Immunology
- Development and Characterization of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Tumorgrafts
- (2012) R. J. Kimple et al. CLINICAL CANCER RESEARCH
- mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas
- (2012) A. A. Molinolo et al. CLINICAL CANCER RESEARCH
- The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and Men
- (2012) S. Kopetz et al. CLINICAL CANCER RESEARCH
- Human Solid Tumor Xenografts in Immunodeficient Mice Are Vulnerable to Lymphomagenesis Associated with Epstein-Barr Virus
- (2012) Kui Chen et al. PLoS One
- A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma
- (2012) S. Sivanand et al. Science Translational Medicine
- The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
- (2011) N. Stransky et al. SCIENCE
- Guidelines for the welfare and use of animals in cancer research
- (2010) P Workman et al. BRITISH JOURNAL OF CANCER
- Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical Implications
- (2009) C. H. Chung et al. CLINICAL CANCER RESEARCH
- Establishment of Patient-Derived Non-Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers
- (2008) I. Fichtner et al. CLINICAL CANCER RESEARCH
- Of Mice and (Wo)Men: Is This Any Way to Test a New Drug?
- (2008) Tufia C. Haddad et al. JOURNAL OF CLINICAL ONCOLOGY
- Global epidemiology of oral and oropharyngeal cancer
- (2008) Saman Warnakulasuriya ORAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started